These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 26613809

  • 21. Thrombotic microangiopathies.
    Rosove MH.
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [Abstract] [Full Text] [Related]

  • 22. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report.
    Wei X, Li J, Zhan X, Tu L, Huang H, Wang Y.
    J Med Case Rep; 2022 Mar 04; 16(1):101. PubMed ID: 35241161
    [Abstract] [Full Text] [Related]

  • 23. Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in Pregnancy.
    Scully M.
    Semin Thromb Hemost; 2016 Oct 04; 42(7):774-779. PubMed ID: 27648610
    [Abstract] [Full Text] [Related]

  • 24. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J, Haller H, Mannucci PM, Nangaku M, Praga M, Rodriguez de Cordoba S.
    Clin Adv Hematol Oncol; 2016 Nov 04; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [Abstract] [Full Text] [Related]

  • 25. Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab.
    Pecoraro C, Ferretti AV, Rurali E, Galbusera M, Noris M, Remuzzi G.
    Am J Kidney Dis; 2015 Dec 04; 66(6):1067-70. PubMed ID: 26409664
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
    Che M, Moran SM, Smith RJ, Ren KYM, Smith GN, Shamseddin MK, Avila-Casado C, Garland JS.
    Kidney Int; 2024 May 04; 105(5):960-970. PubMed ID: 38408703
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.
    Yoshida Y, Miyata T, Matsumoto M, Shirotani-Ikejima H, Uchida Y, Ohyama Y, Kokubo T, Fujimura Y.
    PLoS One; 2015 May 04; 10(5):e0124655. PubMed ID: 25951460
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations.
    Hossain MA, Cheema A, Kalathil S, Bajwa R, Costanzo EJ, Cosentino J, Cheng J, Vachharajani T, Asif A.
    Saudi J Kidney Dis Transpl; 2018 May 04; 29(2):276-283. PubMed ID: 29657193
    [Abstract] [Full Text] [Related]

  • 34. Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Kremer Hovinga JA, Heeb SR, Skowronska M, Schaller M.
    J Thromb Haemost; 2018 Apr 04; 16(4):618-629. PubMed ID: 29356300
    [Abstract] [Full Text] [Related]

  • 35. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.
    Cataland SR, Holers VM, Geyer S, Yang S, Wu HM.
    Blood; 2014 Jun 12; 123(24):3733-8. PubMed ID: 24695849
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.